Pfizer & BioNTech To Consider ‘Future Vaccine Relaunch’ as The Omicron Covid Variant Surges

The Pfizer-BioNTech vaccine is already under scrutiny for the waning efficacy of its mRNA prophylactic therapeutic, which has been marketed as a ‘vaccine’ for Covid-19. The pharmaceutic company, whose Comirnaty vaccine was “fully authorized” for Covid-19 by the Food and Drug Administration was granted full liability shielding by the Biden administration. The so-called ‘vaccines’ (should read Proteinic Inhibitor) have worn off so fast that the Centers for Disease Control is already recommending “boosters.” “BioNTech SE said on Friday it expects more data on a worrying new coronavirus variant detected in South Africa within two weeks to help determine whether its…